• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性3-硝基丙酸诱导的背侧纹状体损伤对基底神经节中大麻素和μ-阿片受体结合的影响。

Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and mu-opioid receptor binding in the basal ganglia.

作者信息

Page K J, Besret L, Jain M, Monaghan E M, Dunnett S B, Everitt B J

机构信息

Medical Research Council Cambridge Centre for Brain Repair, University of Cambridge, UK.

出版信息

Exp Brain Res. 2000 Jan;130(2):142-50. doi: 10.1007/s002210050016.

DOI:10.1007/s002210050016
PMID:10672467
Abstract

Systemic administration of 3-nitropropionic acid (3NPA) in experimental animals produces bilateral striatal lesions similar to those seen in Huntington's disease (HD) caudate and putamen. 3H[-CP55,940 binding to cannabinoid receptors in human basal ganglia nuclei has been shown to be highly susceptible to the earliest pathological changes in the HD brain. In this study, to assess further the suitability of 3NPA-induced striatal lesions as a model for HD neuropathology, we examined the effects of striatal lesions induced by the systemic administration of 3NPA on the binding of 3H[-CP55,940 to pre- and postsynaptic cannabinoid receptors in striatum, globus pallidus, entopeduncular nucleus and substantia nigra pars reticulata and also the effect of 3NPA-induced striatal lesions on the binding of 3H[-DAMGO to mu-opioid receptors in striatal striosomes. Systemic administration of 3NPA induced bilateral and symmetrical lesions in dorsolateral striatum. Within the lesion core, 3H[-CP55,940 and 3H[-DAMGO binding density was reduced to background levels. Beyond the immediate borders of the central core of the 3NPA-induced lesion, striatal binding density was not significantly different from that measured in unlesioned rats. 3H[-CP55,940 binding in globus pallidus, entopeduncular nucleus and substantia nigra in 3NPA-lesioned rats was significantly reduced compared to controls, and the individual decreases were similar for each site. However, these reductions were statistically marginal. These data suggest that, while producing striatal lesions which bear some similarity to those seen in HD, the consequences of 3NPA for striatopallidal and striatonigral efferent projections do not reflect the reported neurodegenerative changes seen in the HD brain.

摘要

在实验动物中全身给予3-硝基丙酸(3NPA)会产生双侧纹状体损伤,类似于亨廷顿舞蹈病(HD)尾状核和壳核中所见的损伤。已表明,在人类基底神经节核中,3H-[-CP55,940与大麻素受体的结合对HD脑最早的病理变化高度敏感。在本研究中,为了进一步评估3NPA诱导的纹状体损伤作为HD神经病理学模型的适用性,我们研究了全身给予3NPA诱导的纹状体损伤对3H-[-CP55,940与纹状体、苍白球、内囊核和黑质网状部突触前和突触后大麻素受体结合的影响,以及3NPA诱导的纹状体损伤对3H-[-DAMGO与纹状体纹状体内μ-阿片受体结合的影响。全身给予3NPA诱导双侧背外侧纹状体对称损伤。在损伤核心内,3H-[-CP55,940和3H-[-DAMGO结合密度降至背景水平。在3NPA诱导损伤的中央核心紧邻边界之外,纹状体结合密度与未损伤大鼠中测得的密度无显著差异。与对照组相比,3NPA损伤大鼠苍白球、内囊核和黑质中的3H-[-CP55,940结合显著降低,且每个部位的个体降低相似。然而,这些降低在统计学上不显著。这些数据表明,虽然3NPA产生的纹状体损伤与HD中所见的损伤有一些相似之处,但3NPA对纹状体苍白球和纹状体黑质传出投射的影响并不反映HD脑中报道的神经退行性变化。

相似文献

1
Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and mu-opioid receptor binding in the basal ganglia.系统性3-硝基丙酸诱导的背侧纹状体损伤对基底神经节中大麻素和μ-阿片受体结合的影响。
Exp Brain Res. 2000 Jan;130(2):142-50. doi: 10.1007/s002210050016.
2
Acute ethanol administration transiently decreases [3H]-DAMGO binding to mu opioid receptors in the rat substantia nigra pars reticulata but not in the caudate-putamen.急性给予乙醇会使大鼠黑质网状部中[3H]-DAMGO与μ阿片受体的结合短暂减少,但在尾状核-壳核中则不会。
Neurosci Res. 2003 Oct;47(2):153-60. doi: 10.1016/s0168-0102(03)00188-3.
3
Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease.亨廷顿舞蹈病转基因模型基底神经节中大麻素CB1受体的mRNA水平、GTP结合蛋白的结合及激活的丧失
Brain Res. 2002 Mar 8;929(2):236-42. doi: 10.1016/s0006-8993(01)03403-5.
4
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.大鼠基底神经节中大麻素受体的神经元定位
Brain Res. 1991 May 3;547(2):267-74. doi: 10.1016/0006-8993(91)90970-7.
5
Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons.大麻素受体在人类发育中和成人基底神经节中的定位。黑质纹状体神经元中的水平更高。
Neurosci Lett. 1992 Dec 14;148(1-2):173-6. doi: 10.1016/0304-3940(92)90832-r.
6
3-Nitropropionic acid neurotoxicity: visualization by silver staining and implications for use as an animal model of Huntington's disease.3-硝基丙酸神经毒性:通过银染法可视化及其作为亨廷顿舞蹈病动物模型的应用意义
Exp Neurol. 1997 Jul;146(1):212-29. doi: 10.1006/exnr.1997.6522.
7
Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.亨廷顿舞蹈病患者黑质中大麻素受体的缺失
Neuroscience. 1993 Oct;56(3):523-7. doi: 10.1016/0306-4522(93)90352-g.
8
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.亨廷顿舞蹈病中的神经退行性变模式:亨廷顿舞蹈病患者人类基底神经节中大麻素、多巴胺、腺苷和GABA(A)受体改变的比较研究
Neuroscience. 2000;97(3):505-19. doi: 10.1016/s0306-4522(00)00008-7.
9
Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.老年大鼠基底神经节中大麻素受体结合、信使核糖核酸水平的丧失以及大麻素激动剂刺激的[35S]鸟苷-5'-O-(硫代)三磷酸结合
Neuroscience. 1998 Jun;84(4):1075-83. doi: 10.1016/s0306-4522(97)00552-6.
10
Initial observations on the distribution of cannabinoid receptor binding sites in the human adult basal ganglia using autoradiography.
Neurosci Lett. 1992 May 11;139(1):7-9. doi: 10.1016/0304-3940(92)90845-x.

引用本文的文献

1
Orexinergic System in Neurodegenerative Diseases.神经退行性疾病中的食欲素能系统。
Front Aging Neurosci. 2021 Aug 17;13:713201. doi: 10.3389/fnagi.2021.713201. eCollection 2021.
2
Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in the rat brain: involvement of CB1 and NMDA receptors.WIN55,212-2对3-硝基丙酸诱导的大鼠脑毒性的神经保护作用:CB1和NMDA受体的参与
Am J Transl Res. 2017 Feb 15;9(2):261-274. eCollection 2017.
3
Huntington's disease and Group I metabotropic glutamate receptors.
亨廷顿病与 I 组代谢型谷氨酸受体。
Mol Neurobiol. 2011 Feb;43(1):1-11. doi: 10.1007/s12035-010-8153-1. Epub 2010 Dec 9.
4
The endocannabinoid system as a target for the treatment of motor dysfunction.内源性大麻素系统作为治疗运动功能障碍的靶点。
Br J Pharmacol. 2009 Apr;156(7):1029-40. doi: 10.1111/j.1476-5381.2008.00088.x. Epub 2009 Feb 13.
5
Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease.神经干细胞脑内移植联合海藻糖摄入可减轻亨廷顿病小鼠模型的病理改变。
J Neurosci Res. 2009 Jan;87(1):26-33. doi: 10.1002/jnr.21817.
6
Oxidative damage and sensitivity to nociceptive stimulus and opioids in aging rats.衰老大鼠的氧化损伤、对伤害性刺激的敏感性及对阿片类药物的反应
Neurobiol Aging. 2009 Jun;30(6):910-9. doi: 10.1016/j.neurobiolaging.2007.09.010. Epub 2007 Nov 7.
7
The endocannabinoid system as an emerging target of pharmacotherapy.内源性大麻素系统作为药物治疗的一个新兴靶点。
Pharmacol Rev. 2006 Sep;58(3):389-462. doi: 10.1124/pr.58.3.2.
8
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.靶向大麻素受体或调节内源性大麻素组织水平或作用的药物的治疗潜力。
AAPS J. 2005 Oct 24;7(3):E625-54. doi: 10.1208/aapsj070364.
9
Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.内源性大麻素的生物合成及其在神经退行性疾病中的作用模式。
Neurotox Res. 2003;5(3):183-200. doi: 10.1007/BF03033139.
10
Loss of cannabinoid CB(1) receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington's disease.实验性亨廷顿舞蹈病大鼠运动不能晚期基底神经节中大麻素CB(1)受体的丧失
Neurotox Res. 2002 Nov-Dec;4(7-8):601-608. doi: 10.1080/10298420290030514.